Bank of America
OCEA

Bank of America’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bank of America’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-92
Closed -$5 – 8772
2025
Q1 		$5 Buy
92
+5
+6% +$1 ﹤0.01% 8247
2024
Q4 		$48 Sell
87
-142
-62% -$112 ﹤0.01% 7873
2024
Q3 		$224 Sell
229
-53
-19% -$57 ﹤0.01% 7540
2024
Q2 		$344 Sell
282
-7,456
-96% -$12.7K ﹤0.01% 7425
2024
Q1 		$29.3K Sell
7,738
-7,680
-50% -$14.4K ﹤0.01% 6671
2023
Q4 		$10.2K Buy
15,418
+15
+0.1% +$21 ﹤0.01% 6906
2023
Q3 		$60.1K Buy
15,403
+3,506
+29% +$16.1K ﹤0.01% 6442
2023
Q2 		$71.5K Buy
11,897
+5,901
+98% +$34.6K ﹤0.01% 6339
2023
Q1 		$39.8K Buy
+5,996
New +$50.7K ﹤0.01% 6567

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

Bank of America's OCEA Position: Q2 2025 in Review

Bank of America sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 92 shares — an estimated $5 sold.

Bank of America first reported a position in OCEA in Q1 2023 and held it in 9 quarters. The position peaked at $71.5K in Q2 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Bank of America reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 92 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $5.
  • Bank of America first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2023 and held it in 9 quarters.
  • Bank of America's Ocean Biomedical, Inc. Common Stock position peaked at $71.5K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.